Jamal Mahajna

3.0k total citations
57 papers, 1.7k citations indexed

About

Jamal Mahajna is a scholar working on Molecular Biology, Pharmacology and Hematology. According to data from OpenAlex, Jamal Mahajna has authored 57 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 25 papers in Pharmacology and 10 papers in Hematology. Recurrent topics in Jamal Mahajna's work include Fungal Biology and Applications (21 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Jamal Mahajna is often cited by papers focused on Fungal Biology and Applications (21 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Jamal Mahajna collaborates with scholars based in Israel, Palestinian Territory and Bulgaria. Jamal Mahajna's co-authors include Solomon P. Wasser, Ben-Zion Zaidman, Mohammed S. Ali-Shtayeh, Zohara Yaniv, Abraham Z. Reznick, Cvetomir M. Denchev, Rachel Amir, Eviatar Nevo, Eran Ben‐Arye and Eviatar Nevo and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Bacteriology and International Journal of Molecular Sciences.

In The Last Decade

Jamal Mahajna

57 papers receiving 1.6k citations

Peers

Countries citing papers authored by Jamal Mahajna

Since Specialization

Citations

This map shows the geographic impact of Jamal Mahajna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamal Mahajna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamal Mahajna more than expected).

Fields of papers citing papers by Jamal Mahajna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamal Mahajna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamal Mahajna. The network helps show where Jamal Mahajna may publish in the future.

Co-authorship network of co-authors of Jamal Mahajna

This figure shows the co-authorship network connecting the top 25 collaborators of Jamal Mahajna. A scholar is included among the top collaborators of Jamal Mahajna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamal Mahajna. Jamal Mahajna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chaga Mushroom Triterpenoids Inhibit Dihydrofolate Reductase and Act Synergistically with Conventional Therapies in Breast Cancer 2024 ·Biomolecules ·Junbiao Wang, Daniela Beghelli, Augusto Amici, Stefania Sut, Stefano Dall’Acqua, Giulio Lupidi, Diego Dal Ben, Onelia Bistoni, Daniele Tomassoni, Barbara Belletti, Sanaa Musa, Jamal Mahajna, Stefania Pucciarelli, Cristina Marchini	3
2	Overcoming Chemoresistance in Cancer: The Promise of Crizotinib 2024 ·Cancers ·Sanaa Musa, (unknown), (unknown), Junbiao Wang, Cristina Marchini, Abed Agbarya, Jamal Mahajna	12
3	Secreted Soluble Factors from Tumor-Activated Mesenchymal Stromal Cells Confer Platinum Chemoresistance to Ovarian Cancer Cells 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), Jacob Gopas, Jamal Mahajna	3
4	Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents 2023 ·Nutrients ·Rosita Gabbianelli, (unknown), (unknown), (unknown), Laura Bordoni, (unknown), Fanrui Zhao, (unknown), Filippo Maggi, Eleonora Spinozzi, Jamal Mahajna	4
5	TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer 2023 ·Journal of Experimental & Clinical Cancer Research ·Jonathan Zorea, Yair Motro, Roei David Mazor, (unknown), Ziv Shulman, Jamal Mahajna, Jacob Moran‐Gilad, Moshe Elkabets	5
6	Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K 2021 ·Annals of Hematology ·Afsar Mian, Isabella Haberbosch, (unknown), Abed Agbarya, (unknown), (unknown), Najib Dally, (unknown), Oliver G. Ottmann, Oliver Hantschel, Ricardo M. Biondi, Martin Ruthardt, Jamal Mahajna	10
7	The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics 2019 ·Biochemical Pharmacology ·(unknown), Betül Karademir, (unknown), (unknown), (unknown), (unknown), Jamal Mahajna, Irina Milisav	32
8	Exploring an herbal “wonder cure” for cancer: a multidisciplinary approach 2016 ·Journal of Cancer Research and Clinical Oncology ·Eran Ben‐Arye, Jamal Mahajna, Radi Aly, Mohammed S. Ali-Shtayeh, Yedidia Bentur, Efraim Lev, Gary Deng, Noah Samuels	20
9	Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I 2012 ·BMC Cancer ·Afsar Mian, (unknown), (unknown), (unknown), (unknown), Yousef Najajreh, Oliver G. Ottmann, Jamal Mahajna, Martin Ruthardt	14
10	The expression of iNOS and nitrotyrosine in colitis and colon cancer in humans 2012 ·Acta Histochemica ·(unknown), Jamal Mahajna, (unknown), Aviva Dahan, Alexandra Blatt, (unknown), Abraham Z. Reznick	76
11	Oleylamine-carbonyl-valinol inhibits auto-phosphorylation activity of native and T315I mutated Bcr-Abl, and exhibits selectivity towards oncogenic Bcr-Abl in SupB15 ALL cell lines 2012 ·Molecular Biology Reports ·Yousef Najajreh, (unknown), (unknown), Soliman Khatib, (unknown), Martin Ruthardt, Jamal Mahajna	5
12	The Shaggy Inc Cap Medicinal Mushroom, Coprinus comatus (O.F.Mull.: Fr.) Pers. (Agaricomycetideae) Substances Interfere with H2O2 Induction of the NF-κB Pathway through Inhibition of IκBα Phosphorylation in MCF7 Breast Cancer Cells 2011 ·International journal of medicinal mushrooms ·Mikheil D. Asatiani, Solomon P. Wasser, Eviatar Nevo, (unknown), Jamal Mahajna, Abraham Z. Reznick	17
13	p185BCR/ABL has a lower sensitivity than p210BCR/ABL to the allosteric inhibitor GNF-2 in Philadelphia chromosome-positive acute lymphatic leukemia 2011 ·Haematologica ·Afsar Mian, (unknown), Yousef Najajreh, Oliver G. Ottmann, Jamal Mahajna, Martin Ruthardt	5
14	Inhibition of TNFα-induced iNOS expression in HSV-tk transduced 9L glioblastoma cell lines by Marasmius oreades substances through NF-κB- and MAPK-dependent mechanisms 2010 ·Molecular Biology Reports ·(unknown), (unknown), Riad Agbaria, (unknown), Solomon P. Wasser, Abraham Z. Reznick, Jamal Mahajna	20
15	Pharmacological Values of Medicinal Mushrooms for Prostate Cancer Therapy: The Case of Ganoderma Lucidum 2008 ·Nutrition and Cancer ·Jamal Mahajna, (unknown), Ben-Zion Zaidman, (unknown), Solomon P. Wasser	50
16	Marasmius oreades substances block NF-κB activity through interference with IKK activation pathway 2008 ·Molecular Biology Reports ·(unknown), Jamal Mahajna, Solomon P. Wasser, (unknown), Cvetomir M. Denchev, (unknown), Eviatar Nevo, Abraham Z. Reznick	14
17	The involvement of nuclear factor-kappa B in cyclooxygenase-2 overexpression in murine colon cancer cells transduced with herpes simplex virus thymidine kinase gene 2006 ·Cancer Gene Therapy ·Alexander Konson, Jamal Mahajna, Abraham Danon, Gilad Rimon, Riad Agbaria	15
18	Fungal substances as modulators of NF-κB activation pathway 2006 ·Molecular Biology Reports ·(unknown), Jamal Mahajna, Abraham Z. Reznick, Solomon P. Wasser, Cvetomir M. Denchev, Eviatar Nevo	19
19	Medicinal mushroom modulators of molecular targets as cancer therapeutics 2005 ·Applied Microbiology and Biotechnology ·Ben-Zion Zaidman, (unknown), Jamal Mahajna, Solomon P. Wasser	351
20	A Four-Amino-Acid Insertion in the Ligand-Binding Domain Inactivates hRXRβ and Renders Dominant Negative Activity 1997 ·DNA and Cell Biology ·Jamal Mahajna, (unknown), Arthur M. Bruskin	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact